Description
Dexend 30 mg is a delayed-release proton pump inhibitor (PPI) containing dexlansoprazole, the R-enantiomer of lansoprazole. It is formulated with dual delayed-release (DDR) technology, utilizing two types of enteric-coated granules that dissolve at different pH levels. This design allows for extended acid suppression by releasing the medication in two phases, enhancing its effectiveness in reducing gastric acid secretion.
Change Language